U.S. authorities have granted a permanent billing code for Blenrep (belantamab mafodotin), an approved treatment for certain adults with hard-to-treat multiple myeloma., a…
Myeloma
A regulatory committee in the European Union has recommended expanding approval of a dual regimen for hard-to-treat myeloma —…
Note: This column describes the author’s own thoughts about GLP-1 agonist medications. Not everyone will have the same response to treatment. Consult your doctor before…
Some mornings the mirror catches me off guard. I know this might sound strange, especially when one is new to caregiving. But I haven’t just…
Adults in the U.S. now have a new generic drug option — Bortezomib for Injection, an equivalent of the approved medication Velcade (bortezomib) —…
Before I got multiple myeloma, I didn’t think much about health insurance. I didn’t even have health insurance 40 years ago! I was young…
Every morning usually starts the same way now. First, I warm the water for my mum’s tea. I prepare it exactly the way she likes…
Tecvayli (teclistamab) extended survival and kept disease under control longer than standard treatments in patients with relapsed or refractory multiple myeloma, meaning the…
About 20 years ago, I worked seven days a week at two different jobs. My weekday job was an hour north of my home, while…
At 2:17 a.m., the house is completely still. No sounds can be heard anywhere at this time of night. I lie on the couch with…
Recent Posts
- Study finds home transfusions safe in hospice care for blood cancer
- Small acts of defiance are the ways we push back against disease
- Under-the-skin myeloma treatment linked to better survival in study
- Add-on therapy shows promise for hard-to-treat AML
- When the caregiver role starts to feel like a second skin